---
title: "Glaxo Group Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340
json: https://whiteintel.dev/api/public/dossier/bc15a382-b626-4703-b25a-5893cefaa340
identifier: gb-coh:305979
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Glaxo Group Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:305979`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/bc15a382-b626-4703-b25a-5893cefaa340  

## Cross-source identity

The same real-world entity, resolved across sources:

- **GLAXO GROUP LIMITED** — companies_house_bulk · `oo:GB-COH-00305979` — https://whiteintel.dev/entity/fb1d9c92-80b5-5f61-88b4-dbc4d71eaae8
- **GLAXO GROUP LIMITED** — GLEIF · `lei:5493006TSD23CIX01B10` — https://whiteintel.dev/entity/df0c7b66-a947-5fe3-b563-359460036544

## Ownership & control

### Holdings / subsidiaries

- **GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/449da0ea-7ac0-5659-8339-4d96ea0c7e09
- **GLAXO OPERATIONS UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f65ae004-5704-5af9-8e89-f34ac2cc722b
- **GLAXO WELLCOME UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/0094c661-0ce9-5b24-8f2f-c0ccaae6c4f1
- **DOMANTIS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/244798d7-2005-5445-984c-83a3c47b3d78
- **GLAXOSMITHKLINE UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/a093deef-8da6-5842-b50e-84acf1d410b8
- **GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/bd0db99a-95b2-50a7-90c3-ca07d36ee2d0
- **CLARGES PHARMACEUTICALS TRUSTEES LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/76f8a092-39e8-58ef-9d94-49c11bc1fc16
- **ACTION POTENTIAL VENTURE CAPITAL LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/653050f5-6f60-436a-8d1e-bd9e8145f13b
- **EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/4401174d-4f25-5698-8e3a-3f933dd54455
- **MONTROSE FINE CHEMICAL COMPANY LTD.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/0aeb1cf6-554d-5033-b696-e5a5b7343823
- **GLAXOSMITHKLINE EXPORT LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/893203cd-f7d8-5931-92e2-c77f6b4671e5

### UBO chain (walk to the ultimate owner)

A **12-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Glaxo Group Limited** — https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Glaxo Group Limited**. Human view: https://whiteintel.dev/entity/bc15a382-b626-4703-b25a-5893cefaa340 · Structured JSON: https://whiteintel.dev/api/public/dossier/bc15a382-b626-4703-b25a-5893cefaa340._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._